<scp>TUXEDO</scp> : a phase I/ <scp>II</scp> trial of cetuximab with chemoradiotherapy in muscle‐invasive bladder cancer-Reference-Cited by-同舟云学术

TUXEDO : a phase I/ II trial of cetuximab with chemoradiotherapy in muscle‐invasive bladder cancer

Published:2022-08-16 Issue:1 Volume:131 Page:63-72
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU International

Author:

James Nicholas D.¹,Liu Wenyu²,Pirrie Sarah²^ORCID,Kaur Baljit²,Hendron Carey²,Ford Daniel³,Zarkar Anjali³^ORCID,Viney Richard³,Southgate Elizabeth³,Desai Amisha³,Hussain Syed A.⁴,Barber Jim,Syndikus Isabel,Malik Zafar,Eswar Chinnamani,Mangar Stephen,Money‐Kyrle Julian,Lydon Anna,Van Der Voet Johannes,James Nicholas,Zarkar Anjali,Ford Dan,

Affiliation:

1. Institute of Cancer Research London UK

2. Cancer Research UK Clinical Trials Unit (CRCTU) University of Birmingham Birmingham UK

3. Cancer Centre University Hospitals Birmingham NHS Foundation Trust Birmingham UK

4. Department of Oncology & Metabolism The Medical School Sheffield UK

Funder

Cancer Research UK

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bju.15864

Reference30 articles.

1. Cancer Research UK bladder cancer statistics. Available at:https://www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/bladder‐cancer. Accessed April 2021

2. Combined-Modality Treatment and Selective Organ Preservation in Invasive Bladder Cancer: Long-Term Results

3. Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

4. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees

5. Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landscape of targeted therapies for advanced urothelial carcinoma;Exploration of Targeted Anti-tumor Therapy;2024-06-21

2. Combining theranostic/particle therapy with immunotherapy for the treatment of GU malignancies;BJUI Compass;2023-12-13

3. Pembrolizumab with Chemoradiation as Treatment for Muscle-invasive Bladder Cancer: Analysis of Safety and Efficacy of the PCR-MIB Phase 2 Clinical Trial (ANZUP 1502);European Urology Oncology;2023-10